Gastric cancer Clinical Trials in Manchester, CT
As of June 2026, 1 paid clinical trial is recruiting for Gastric cancer in Manchester, Connecticut. Recruiting Gastric cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Manchester
Filter results
1 clinical trial for Gastric cancer
·Clear filters·↓ Download CSVAbout research studies in Manchester
Manchester has approximately 16 recruiting research studies across a wide range of therapeutic areas. Connecticut hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Manchester
Researchers run research studies in Manchester, CT at 8 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Hartford HealthCare - Manchester | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 7 |
| Retina Consultants | Neovascular Age-related Macular Degeneration, Radiation Retinopathy, Visual Impairment | 2 |
| Retina Consultants, PC | Macular Edema Secondary to Inflammation | 2 |
| CBCC Global Research Site:005 | Age-related Wet Macular Degeneration | 1 |
| Hartford HealthCare Cancer Institute at Manchester Medical Hospital | Anal Cancer, Bile Duct Cancer, Bladder Cancer | 1 |
| Hartford Healthcare Medical Group-Manchester | Cervical Cancer | 1 |
| Retina Consultants PC | Age-Related Macular Degeneration, Age-related Macular Degeneration (ARMD), Geographic Atrophy Secondary to Age-related Macular Degeneration | 1 |
| Retina Consultants, P.C. /ID# 273610 | AMD, CNV, Wet Age-related Macular Degeneration | 1 |
Active & Upcoming Studies in Manchester (2026)
Recruiting trials in Manchester grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (8 active studies)
- Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial · Phase 3 · National Cancer Institute (NCI)
- Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer · Phase 3 · Alliance for Clinical Trials in Oncology
Eye & vision (6 active studies)
- A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK · Phase 3 · Kodiak Sciences Inc
- A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE · Phase 3 · Kodiak Sciences Inc
Common conditions studied in Manchester
- Breast Cancer (2 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Macular Edema Secondary to Inflammation (2 active studies). Recruiting Macular Edema Secondary to Inflammation studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- AMD (1 active study). Recruiting AMD studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Advanced Esophageal Adenocarcinoma (1 active study). Recruiting Advanced Esophageal Adenocarcinoma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Advanced Gastric Adenocarcinoma (1 active study). Recruiting Advanced Gastric Adenocarcinoma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Advanced Gastroesophageal Junction Adenocarcinoma (1 active study). Recruiting Advanced Gastroesophageal Junction Adenocarcinoma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Manchester
- Alliance for Clinical Trials in Oncology
- Jaeb Center for Health Research
- Kodiak Sciences Inc
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
Local regulations and guidelines
Clinical trials in Connecticut are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Connecticut research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Manchester. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Manchester
Hipa.ai aggregates every recruiting study in Manchester from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Manchester?
There are approximately 16 recruiting clinical trials in Manchester, Connecticut listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Manchester pay participants?
Most recruiting trials in Manchester compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Manchester?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Manchester?
The most common conditions under active study in Manchester include Breast Cancer (2), Macular Edema Secondary to Inflammation (2), AMD (1), Advanced Esophageal Adenocarcinoma (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Manchester?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Manchester on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Manchester?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Manchester?
Recruiting research sites in Manchester include Hartford HealthCare - Manchester, Retina Consultants, Retina Consultants, PC, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Manchester right now?
The largest active categories in Manchester are Cancer & tumors (8), Eye & vision (6). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.